Methotrexate Prescribed Daily: Catching a Potentially Fatal Dosing Error
A 74-year-old woman with rheumatoid arthritis presents to a community pharmacy with a new prescription: methotrexate 2.5 mg tablets, 'Take 1 tablet by mouth every day for joint pain.' The prescriber is an urgent care physician who saw her for a flare. Her rheumatologist usually prescribes methotrexate 15 mg once weekly plus folic acid 1 mg daily. She also takes ibuprofen 400 mg three times daily as needed, lisinopril 10 mg daily, and omeprazole 20 mg daily. Recent labs: serum creatinine 1.4 mg/dL, eGFR 38 mL/min/1.73 m², ALT 45 U/L, WBC 3.8 × 10^9/L. The patient says she was told to 'take the arthritis pill every day until the flare settles.' The pharmacy is busy, and the label has already been generated. The patient is waiting at the counter with the bag. She denies fever, mouth ulcers, or shortness of breath.
1. What is the most likely explanation for this prescription, and why is daily methotrexate dangerous in this patient?
Read the worked answer
The prescription almost certainly represents a prescriber error: methotrexate for rheumatoid arthritis is dosed once weekly, not daily. Daily dosing is a well-known cause of fatal methotrexate toxicity, even when the weekly total looks similar, because continuous exposure allows intracellular polyglutamation and prolonged folate antagonism rather than intermittent pulse therapy.
This patient is especially vulnerable:
- Renal impairment: eGFR 38 mL/min/1.73 m² reduces methotrexate clearance; parent drug and metabolites accumulate.
- NSAID exposure: ibuprofen may reduce renal perfusion and compete with methotrexate for tubular secretion, raising methotrexate concentrations.
- Low WBC and mildly elevated ALT: baseline marrow and hepatic vulnerability increase the consequence of further folate antagonism.
- Omeprazole: proton pump inhibitors can delay methotrexate elimination, particularly at higher doses.
The danger is not theoretical: daily methotrexate can cause severe myelosuppression, mucositis, hepatotoxicity, pneumonitis, and acute kidney injury. The label must not be dispensed as written; the pharmacist must intervene before the patient leaves.
2. What immediate actions should the pharmacist take before the patient leaves the pharmacy?
Read the worked answer
- Do not dispense the bag as labeled. Hold the product and speak to the patient privately, away from the counter.
- Verify the patient's actual regimen. Ask what day she usually takes methotrexate, what the rheumatologist told her, and whether she has already taken any of the new tablets. If she has taken even one daily dose, quantify the exposure and arrange urgent clinical assessment.
- Contact the urgent care prescriber. State the concern directly: 'The prescription reads daily; methotrexate for rheumatoid arthritis is weekly. Please confirm the intended dose and frequency.' Do not alter the prescription without authorization.
- Contact the rheumatologist if the urgent care prescriber cannot be reached. The usual regimen is 15 mg once weekly with folic acid 1 mg daily; a corrected prescription should specify the weekly dose and day.
- Document everything: the prescription as received, the conversation, the prescriber contacted, the corrected order, and the counseling given.
- Escalate if the prescriber insists on daily dosing. Involve the pharmacist-in-charge and follow the pharmacy's error-reporting policy. A daily methotrexate order is a patient-safety event, not a labeling preference.
3. What counseling and monitoring should accompany the corrected weekly prescription?
Read the worked answer
Counsel the patient using a concrete weekly schedule:
- Take the entire weekly dose on one chosen day each week, not daily. Mark a calendar and avoid doubling a missed dose; call the prescriber for advice.
- Take folic acid 1 mg daily, but many rheumatologists advise not taking it on the same day as methotrexate; follow the rheumatologist's specific instruction.
- Avoid ibuprofen and other NSAIDs unless the prescriber specifically approves them; acetaminophen may be preferable for pain, with attention to total daily dose.
- Avoid alcohol, trimethoprim-sulfamethoxazole, and other interacting drugs without pharmacist review.
- Report fever, sore throat, mouth ulcers, bruising, bleeding, shortness of breath, dark urine, or jaundice promptly.
Monitoring should include CBC, liver enzymes, and serum creatinine at baseline and periodically, with more frequent checks given her CKD and low WBC. Reassess the ibuprofen use and consider whether omeprazole is still needed. Document the near-miss and use it for pharmacy error-prevention review.